Click the icon to add a specified price to your Dashboard list. This makes it easy to keep track on the prices that matter most to you.
Creating synergies in bioplastic solutions by leveraging Mitsui Chemicals’ technologies and Materia Bioworks’ AI-powered platform
Mitsui Chemicals, Inc. announced that it has made a minority investment in Materia Bioworks Inc. through 321Catalyst™, its corporate venture capital (CVC) fund.
About Materia Bioworks
Materia Bioworks is a startup utilizing computational chemistry and AI to develop a platform (“MAPS”) that can efficiently design and formulate sustainable materials, such as bioplastics. By leveraging computational chemistry and AI, the company streamlines product development using bioplastics, a process that traditionally required significant time and cost, thereby reducing development time and costs while also driving down the cost of bioplastics themselves.
Purpose of the Investment
By utilizing their biomass materials in Materia Bioworks’ bioplastic design services, Mitsui Chemicals aims to expand its provision of bioplastic materials offering to customers globally. Furthermore, Mitsui Chemicals will collaborate with Materia Bioworks to meet the performance and quality requirements of customers through the possible joint development of new bioplastic materials.
PLease click here to download full PDF file
Note: This story has not been edited by The Polymerupdate Editorial team and is auto-generated from a syndicated feed.
